Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Date of Report: November 13, 2025
Reporting Period: Single event date (November 13, 2025)
Business Context: The Company is an emerging growth company incorporated in Texas, trading on the Nasdaq Capital Market. This filing addresses a specific corporate communication event rather than a standard financial reporting period.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow metrics, margin analysis, debt levels, or liquidity ratios. The filing text does not provide a clear value for any financial metric.
Material Changes
Item 8.01 Other Events: The Company issued a press release on November 13, 2025, titled "Mangoceuticals Provides Clarification Regarding Availability of Branded GLP." This release serves to clarify a prior press release issued by the Company on the same date. No material changes to financial condition or operations are reported in this document.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release by reference (Exhibit 99.1) regarding the availability of branded GLP products. Specific details of the clarification are contained within the exhibit and not explicitly detailed in the body of the 8-K.
Forward-Looking Statements: The document includes standard disclaimers stating that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. The Company undertakes no obligation to update these statements.
Risks: General risks are referenced as being detailed in the Company's periodic filings (10-K, 10-Q) and risk factor sections.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 13, 2025) to understand the specific clarification regarding the availability of branded GLP products.
- Compare the clarifying press release with the original press release issued earlier on November 13, 2025, to identify the specific discrepancy or correction.
- Verify the Company's status as an emerging growth company and its implications for financial reporting standards.
- Consult recent Form 10-Q or 10-K filings for actual financial performance data, as this 8-K contains no financial metrics.